Medivir Notes that Partner Tibotec Announced Week 24 Interim Results from Phase 2b TMC435 PILLAR Study to be Presented …
November 2, 2010 by
Filed under online class registration
Medivir Notes that Partner Tibotec Announced Week 24 Interim Results from Phase 2b TMC435 PILLAR Study to be Presented …
Regulatory News:
Read more on Business Wire via Yahoo! Finance
Positive data from Gloucester Pharmaceuticals’ ISTODAX study presented at the ASH meeting
December 6, 2009 by
Filed under class registration software
Positive data from Gloucester Pharmaceuticals’ ISTODAX study presented at the ASH meeting
Gloucester Pharmaceuticals announced today the presentation of positive data from an analysis of ISTODAX® (romidepsin) in a subset of patients from Gloucester’s registration study in cutaneous T-cell lymphoma (CTCL) at the 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, [...]